Skip to search boxSkip to navigationSkip to main content

Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke

  • Svetlana A. Dambinova
    ,
  • Kerstin Bettermann
    ,
  • Theodore Glynn
    ,
  • Matthew Tews
    ,
  • David Olson
    ,
  • Joseph D. Weissman
  • Kennesaw State University
    ,
  • Pennsylvania State University
    ,
  • Michigan State University
    ,
  • Emory University
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Background: The acute assessment of patients with suspected ischemic stroke remains challenging. The use of brain biomarker assays may improve the early diagnosis of ischemic stroke. The main goal of the study was to evaluate whether the NR2 peptide, a product of the proteolytic degradation of N-methyl-D-aspartate (NMDA) receptors, can differentiate acute ischemic stroke (IS) from stroke mimics and persons with vascular risk factors/healthy controls. A possible correlation between biomarker values and lesion sizes was investigated as the secondary objective. Methods and Findings: A total of 192 patients with suspected stroke who presented within 72 h of symptom onset were prospectively enrolled. The final diagnosis was determined based on clinical observations and radiological findings. Additionally gender- and age-matched healthy controls (n = 52) and persons with controlled vascular risk factors (n = 48) were recruited to compare NR2 peptide levels. Blinded plasma was assayed by rapid magnetic particles (MP) ELISA for NR2 peptide within 30 min and results for different groups compared using univariate and multivariate statistical analyses. There was a clinical diagnosis of IS in 101 of 192 (53%) and non-stroke in 91 (47%) subjects. The non-stroke group included presented with acute stroke symptoms who had no stroke (n = 71) and stroke mimics (n = 20). The highest NR2 peptide elevations where found in patients with IS that peaked at 12 h following symptom onset. When the biomarker cut off was set at 1.0 ug/L, this resulted in a sensitivity of 92% and a specificity of 96% to detect IS. A moderate correlation (rs = 0.73) between NR2 peptide values and acute ischemic cortical lesions (<200 mL) was found. Conclusions: This study suggests that the NR2 peptide may be a brain specific biomarker to diagnose acute IS and may allow the differentiation of IS from stroke mimics and controls. Additional larger scale clinical validation studies are required.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

e42362

Journal (Volume, Issue Number)

PloS one (Volume 7, Issue 7)

Publication milestones

  • Published - 07/27/2012

Publication status

Published - 07/27/2012

ISSN

1932-6203

Publication IDs

  • Scopus: 84864402371
  • PubMed: 22848761
  • ORCID: /0000-0002-4304-3452/work/65876363

Publication metrics

Metrics

SciVal
FWCI
0.90
SciVal
Author count
7
SciVal
citations
37
SciVal
Paper percentile
89
Scopus
citations
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Usage
350
Captures
56
Citation count
64